摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-溴苯基磺酰)吡咯啉 | 136350-52-2

中文名称
1-(4-溴苯基磺酰)吡咯啉
中文别名
1-(4-溴苯基磺酰基)吡咯烷
英文名称
1-((4-bromophenyl)sulfonyl)pyrrolidine
英文别名
1-(4-Bromophenylsulfonyl)pyrrolidine;1-(4-bromophenyl)sulfonylpyrrolidine
1-(4-溴苯基磺酰)吡咯啉化学式
CAS
136350-52-2
化学式
C10H12BrNO2S
mdl
MFCD00584577
分子量
290.181
InChiKey
JMOJWOSNSJXQMT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    80-84°C
  • 沸点:
    383.1±44.0 °C(Predicted)
  • 密度:
    1.583±0.06 g/cm3(Predicted)
  • 溶解度:
    41.5 [ug/mL]

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    45.8
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xi
  • 海关编码:
    2935009090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    请保持冷敷。

SDS

SDS:2a99f2d9f67e9e22920ca81491dc0766
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 1-(4-Bromophenylsulfonyl)pyrrolidine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 1-(4-Bromophenylsulfonyl)pyrrolidine
CAS number: 136350-52-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H12BrNO2S
Molecular weight: 290.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide, sulfur oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer’s Disease: Design, Synthesis, and Characterization of Pyrazines
    摘要:
    Glycogen synthase kinase-3 beta, also called tau phosphorylating kinase, is a proline-directed serine/threonine kinase which was originally identified due to its role in glycogen metabolism. Active forms of GSK3 beta localize to pretangle pathology including dystrophic neuritis and neurofibrillary tangles in Alzheimer's disease (AD) brain. By using a high throughput screening (HTS) approach to search for new chemical series and cocrystallization of key analogues to guide the optimization and synthesis of our pyrazine series, we have developed highly potent and selective inhibitors showing cellular efficacy and blood-brain barrier penetrance. The inhibitors are suitable for in vivo efficacy testing and may serve as a new treatment strategy for Alzheimer's disease.
    DOI:
    10.1021/jm201724m
  • 作为产物:
    描述:
    1,4-丁二醇4-溴苯磺酰胺三氟甲磺酸酐 作用下, 以 甲苯 为溶剂, 反应 48.0h, 以92%的产率得到1-(4-溴苯基磺酰)吡咯啉
    参考文献:
    名称:
    N-Alkylation of Sulfonamides with Alcohols by Tf2O
    摘要:
    N-磺酰吡咯烷和N-烷基磺酰胺通过Tf2O对磺酰胺与1,4-二醇或醇的烷基化反应高效合成。该反应在温和的反应条件下进行,产率中等到高,并且耐受芳香族和脂肪族磺酰胺。
    DOI:
    10.1246/bcsj.20150005
点击查看最新优质反应信息

文献信息

  • Iodine-catalyzed sulfonylation of sulfonyl hydrazides with <i>tert</i>-amines: a green and efficient protocol for the synthesis of sulfonamides
    作者:Jinyang Chen、Xiaoran Han、Lan Mei、Jinchuan Liu、Kui Du、Tuanwu Cao、Qiang Li
    DOI:10.1039/c9ra07361b
    日期:——
    This study provides a direct, sustainable and eco-friendly method for the synthesis of various sulfonamides via the sulfonylation of sulfonyl hydrazides with tert-amines. The method utilizes sulfonyl hydrazides to oxidize and couple with tertiary amines through selective cleavage of C–N bonds. In this reaction, molecular iodine was used as the catalyst and t-butyl hydroperoxide was used as the oxidant
    该研究为通过磺酰肼与叔胺磺酰化合成各种磺胺类药物提供了一种直接、可持续和环保的方法。该方法利用磺酰肼氧化并通过选择性裂解 C-N 键与叔胺偶联。在该反应中,分子碘用作催化​​剂,叔丁基过氧化氢用作氧化剂。
  • PIPERIDINE DERIVATIVES FOR GPR119 AGONIST
    申请人:CHONG KUN DANG PHARMACEUTICAL CORP.
    公开号:US20150166480A1
    公开(公告)日:2015-06-18
    The present invention relates to novel piperidine derivatives, stereoisomers thereof or pharmaceutically acceptable salts thereof; methods for preparing the compound; and pharmaceutical compositions comprising the compound. The novel piperidine derivatives, according to the present invention, having an effect as GPR119 agonist can be used for treatment of metabolic disorders, including diabetes mellitus (especially type II) and related disorders.
    本发明涉及新型的哌啶衍生物、它们的立体异构体或药用可接受的盐;制备该化合物的方法;以及包含该化合物的药物组合物。根据本发明,具有GPR119激动剂作用的新型哌啶衍生物可用于治疗代谢紊乱,包括糖尿病(尤其是II型)及相关疾病。
  • Dynamic multiligand catalysis: A polar to radical crossover strategy expands alkyne carboboration to unactivated secondary alkyl halides
    作者:Shin-Ho Kim-Lee、Pablo Mauleón、Ramón Gómez Arrayás、Juan C. Carretero
    DOI:10.1016/j.chempr.2021.06.002
    日期:2021.8
    triggers cooperative polar/radical pathways in a single catalytic cycle. This strategy has been applied to address a restricting limitation inherent to Cu-catalyzed B2pin2-carboboration of alkynes—the very low reactivity of the intermediate vinyl-Cu(I) species, which renders conventional methods ineffective with alkyl electrophiles other than simple primary halides. The crossover strategy enabled by
    我们描述了基于前所未有的动态多配体配位池的 Cu 催化的双重策略,该池在单个催化循环中触发合作的极性/自由基途径。该策略已被应用于解决 Cu 催化的 B 2 pin 2固有的限制性限制-炔烃的碳硼化——中间体乙烯基-Cu(I) 物质的反应性非常低,这使得传统方法对烷基亲电试剂无效,而不是简单的伯卤化物。通过有机金属中间体中的配体交换实现的交叉策略克服了这一反应性问题,将碳硼化的范围扩大到未活化的仲烷基卤化物,并开辟了获得立体定义的四取代乙烯基硼酸酯的新途径。该方法具有区域选择性和立体选择性,显示出优异的官能团耐受性,并允许在任一反应伙伴处掺入复杂的碳环和杂环片段。
  • TBAI-catalyzed selective synthesis of sulfonamides and β-aryl sulfonyl enamines: coupling of arenesulfonyl chlorides and sodium sulfinates with <i>tert</i>-amines
    作者:Hongmei Jiang、Xiaoyue Tang、Zhihui Xu、Huixian Wang、Kang Han、Xiaolan Yang、Yuanyuan Zhou、Yong-Lai Feng、Xian-Yong Yu、Qingwen Gui
    DOI:10.1039/c8ob02992j
    日期:——
    A simple, practical and metal-free method has been developed for the synthesis of sulfonamides and β-arylsulfonyl enamines via the selective cleavage of C–N and C–H bonds through the iodine-catalyzed oxidation of arenesulfonyl chlorides and sodium sulfinates with tert-amines. The method uses commercially available inexpensive catalysts and oxidants, and has a wide substrate scope and operational simplicity
    一种简单,实用和不含金属的方法已被开发用于磺酰胺和β-芳基磺酰基的烯胺的合成通过的C-N和C-H键的选择性裂解通过芳烃磺酰基氯化物和钠基亚磺酸盐的碘催化氧化用叔-胺类。该方法使用可商购的廉价催化剂和氧化剂,并且具有广泛的底物范围和操作简便性。
  • [EN] 20-HETE FORMATION INHIBITORS<br/>[FR] INHIBITEURS DE FORMATION DE 20-HETE
    申请人:UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    公开号:WO2020163689A1
    公开(公告)日:2020-08-13
    This disclosure provides novel heterocyclic compounds and methods for inhibiting the enzyme CYP4. Further disclosed methods include: a method of inhibiting the biosynthesis of 20-hydroxyeicosatetraenoic acid (20-HETE) in a subject in need thereof and a method of producing neuroprotection and decreased brain damage by preventing cerebral microvascular blood flow impairment and anti-oxidant mechanisms in a subject experiencing or having experienced an ischemic event.
    本公开提供了新颖的杂环化合物和抑制酶CYP4的方法。进一步公开的方法包括:一种抑制需要该物质的受试者体内20-羟基二十碳五烯酸(20-HETE)生物合成的方法,以及通过防止脑微血管血流受损和抗氧化机制来产生神经保护和减少脑损伤的方法,适用于正在经历或曾经经历缺血事件的受试者。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐